Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease

被引：0
|
作者：
Patriarca, F
Sperotto, A
Prosdocimo, S
Damiani, D
Morreale, G
Olivieri, A
Bonifazi, F
Milone, G
Peccatori, J
Corradini, P
Fanin, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [31] Steroid-Refractory Acute Graft-versus-Host Disease: Is There an Effective Therapy?
    Antin, Joseph H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 146 - 148
  • [32] Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease
    Agrawal, Vaibhav
    Griffin, Shawn P.
    Koch, Lindsey
    Thakrar, Teresa C.
    Ervin, Kirsten D.
    Schmidt, Caitlin A.
    Cox, Elizabeth A.
    Schwartz, Jennifer E.
    Abonour, Rafat
    Robertson, Michael J.
    Brinda, Bryan J.
    Nelson, Robert P., Jr.
    Farag, Sherif S.
    Abu Zaid, Mohammad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [33] Novel strategies for steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Vogelsang, GB
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 40 - 44
  • [34] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Krejci, M
    Doubek, M
    Buehler, T
    Brychtova, Y
    Vorlicek, J
    Mayer, J
    ANNALS OF HEMATOLOGY, 2005, 84 (10) : 681 - 685
  • [35] Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease
    Alexander Coltoff
    Guido Lancman
    Sara Kim
    Amir Steinberg
    Bone Marrow Transplantation, 2018, 53 : 900 - 904
  • [36] Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease
    Kaipe, H.
    Erkers, T.
    Nava, S.
    Uzunel, M.
    Iwarsson, E.
    Conrad, R.
    Westgren, M.
    Mattsson, J.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S175 - S176
  • [37] Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Ringden, Olle
    Erkers, Tom
    Nava, Silvia
    Uzunel, Mehmet
    Iwarsson, Erik
    Conrad, Reka
    Westgren, Magnus
    Mattsson, Jonas
    Kaipe, Helen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S141 - S142
  • [38] Etanercept as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients
    Faraci, Maura
    Calevo, Maria Grazia
    Giardino, Stefano
    Leoni, Massimiliano
    Ricci, Erica
    Castagnola, Elio
    Lanino, Edoardo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 743 - 748
  • [39] Infliximab as treatment for steroid refractory acute and chronic graft-versus-host disease.
    Trenschel, R
    Ditschkowski, M
    Biersack, H
    Trampenau, C
    Steckel, NK
    Peceny, R
    Ottinger, H
    Elmaagacli, A
    Scheulen, ME
    Beelen, DW
    Schaefer, UW
    BLOOD, 2002, 100 (11) : 450B - 450B
  • [40] Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Ringden, Olle
    Erkers, Tom
    Nava, Silvia
    Uzunel, Mehmet
    Iwarsson, Erik
    Conrad, Reka
    Westgren, Magnus
    Mattsson, Jonas
    Kaipe, Helen
    STEM CELLS, 2013, 31 (03) : 592 - 601
12345